Menon S D, Guy G R, Tan Y H
Institute of Molecular and Cell Biology, National University of Singapore.
J Biol Chem. 1995 Aug 11;270(32):18881-7. doi: 10.1074/jbc.270.32.18881.
Inhibitors of phosphotyrosyl protein phosphatases, pervanadate and phenylarsine oxide, abrogate tumor necrosis factor (TNF)-induced nuclear factor kappa B (NF-kappa B) nuclear translocation in transformed cell lines (U-937 and Jurkat) and primary fibroblasts (MRC-5 and REF). The inhibitors also abrogate NF-kappa B activation by the phosphoseryl/threonyl protein phosphatase inhibitor okadaic acid in U-937 cells. Inhibition of NF-kappa B activation is not due to a general inhibitory effect since neither pervanadate nor phenylarsine oxide treatment affected the constitutive DNA-binding activity of the transcription factors octamer-1 and cAMP response element-binding protein in U-937 cells, nor did these compounds inhibit the TNF-induced phosphorylation of proteins, viz. hsp-27, eukaryotic initiation factor 4e, and pp19, in MRC-5 fibroblasts. Overexpression of the protein-tyrosine phosphatase HPTP alpha resulted in a constitutive nuclear NF-kappa B-like DNA-binding activity in REF cells. Conversely, treatment of human protein-tyrosine phosphatase alpha-overexpressing cells with phenylarsine oxide led to a loss of the constitutive NF-kappa B activity. The presence of a tyrosine phosphorylation site on the inhibitor of NF-kappa B (I kappa B-alpha) suggested that it could be a target for TNF/okadaic acid-induced tyrosine dephosphorylation. However, no tyrosine phosphorylation was detected on I kappa B-alpha fron unstimulated cells, while TNF/okadaic acid-treated cells showed increased phosphorylation of I kappa B-alpha exclusively at serine residue(s). Treatment of cells with pervanadate inhibited TNF-induced I kappa B-alpha phosphorylation and degradation, whereas the serine protease inhibitors tosylphenylalanyl chloromethyl ketone and N alpha-p-tosyl-L-lysine chloromethyl ketone prevented TNF-induced I kappa B-alpha degradation and NF-kappa B nuclear translocation, but not the TNF-induced phosphorylation of I kappa B-alpha. The data suggest that TNF and okadaic acid induce the activation of a putative protein-tyrosine phosphatase(s), leading to I kappa B-alpha serine phosphorylation and degradation and NF-kappa B nuclear translocation.
磷酸酪氨酸蛋白磷酸酶抑制剂过氧钒酸盐和氧化苯胂,可消除肿瘤坏死因子(TNF)诱导的转化细胞系(U-937和Jurkat)及原代成纤维细胞(MRC-5和REF)中核因子κB(NF-κB)的核转位。这些抑制剂还可消除U-937细胞中由磷酸丝氨酸/苏氨酸蛋白磷酸酶抑制剂冈田酸诱导的NF-κB激活。NF-κB激活的抑制并非由于普遍的抑制作用,因为过氧钒酸盐或氧化苯胂处理均未影响U-937细胞中转录因子八聚体-1和cAMP反应元件结合蛋白的组成性DNA结合活性,这些化合物也未抑制MRC-5成纤维细胞中TNF诱导的蛋白质磷酸化,即热休克蛋白27(hsp-27)、真核起始因子4E(eukaryotic initiation factor 4E)和pp19。蛋白酪氨酸磷酸酶HPTPα的过表达导致REF细胞中出现组成性核NF-κB样DNA结合活性。相反,用氧化苯胂处理过表达人蛋白酪氨酸磷酸酶α的细胞会导致组成性NF-κB活性丧失。NF-κB抑制剂(IκB-α)上存在酪氨酸磷酸化位点,提示其可能是TNF/冈田酸诱导的酪氨酸去磷酸化的靶点。然而,在未刺激细胞的IκB-α上未检测到酪氨酸磷酸化,而经TNF/冈田酸处理的细胞仅在丝氨酸残基处显示IκB-α磷酸化增加。用过氧钒酸盐处理细胞可抑制TNF诱导的IκB-α磷酸化和降解,而丝氨酸蛋白酶抑制剂甲苯磺酰苯丙氨酰氯甲基酮和Nα-p-甲苯磺酰-L-赖氨酸氯甲基酮可阻止TNF诱导的IκB-α降解和NF-κB核转位,但不能阻止TNF诱导的IκB-α磷酸化。数据表明,TNF和冈田酸诱导一种假定的蛋白酪氨酸磷酸酶激活,导致IκB-α丝氨酸磷酸化和降解以及NF-κB核转位。